BCL2 and plasma cell myeloma: In a previous study, Duus et al (23) investigated Hsp90 expression in a myeloma cell line (U266) using immunofluorescence and flow cytometric analysis, and the results demonstrated that GA treatment resulted in a significant increase in apoptosis and reduction in Bcl-2 expression levels.